trending Market Intelligence /marketintelligence/en/news-insights/trending/i-vm7hzr4uyu-fu1yesiiw2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Avadel Pharmaceuticals adds director

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


Avadel Pharmaceuticals adds director

Avadel Pharmaceuticals plc has appointed Kevin Kotler to the board, effective Dec. 11.

Kotler is the founder and portfolio manager of Broadfin Capital LLC and a director of BioDelivery Sciences International Inc.

Dublin-based Avadel Pharmaceuticals develops and commercializes pharmaceutical products primarily for treating urology and sleep medicines.